About
Pain therapies
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
15
As Collaborator
1
Total Enrollment
2,208
By Phase
PHASE1: 9PHASE3: 3PHASE2: 4
By Status
COMPLETED: 13NOT_YET_RECRUITING: 1RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07122453Lead Sponsor
Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain
PHASE1Not yet recruiting
16 participants
Started: Aug 31, 2025 · Completed: Jun 30, 2026
NCT05184816Collaborator
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
PHASE1Recruiting
35 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2025
NCT04857957Lead Sponsor
Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN
PHASE1Completed
46 participants
Started: Apr 14, 2021 · Completed: Aug 30, 2023
NCT04154501Lead Sponsor
A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects
PHASE1Completed
68 participants
Started: Dec 4, 2018 · Completed: Aug 26, 2019
NCT03661996Lead Sponsor
An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA
PHASE3Completed
854 participants
Started: Sep 18, 2018 · Completed: Oct 22, 2019
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...